Navigation Links
BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research
Date:9/19/2012

COLUMBIA, Md., Sept. 19, 2012 /PRNewswire/ -- BioFortis Inc., a leading software company in the clinical and translational research space, today introduced its Next Generation Biobanking software platform for biomarker-based clinical research. It will help pharmaceutical, government and academic research centers involved in biomarker-based clinical and translational studies to safely and effectively conduct externalized, science-driven collaborative studies.

As biomarker-based clinical research has become more commonplace, organizations have looked to biobanks to help drive these studies. However, this approach poses significant challenges to conventional biobanks and their software. The Next Generation Biobanking software platform is designed to overcome these challenges by harmonizing biospecimen data with clinical and molecular data in a collaborative environment that emphasizes scientific insights, while ensuring security and compliance.

At the core of the Next Generation Biobanking software solution is the Labmatrix® platform. Labmatrix goes beyond the sample-centric workflows of conventional biobanking software by integrating patient, clinical, specimen, genetic and molecular assay data, to deliver holistic views of studies. Multi-level user access control ensures that all collaborators can work effectively while maintaining relevant privacy and regulatory compliance objectives.

Driving scientific insights is one of the key benefits of Next Generation Biobanking software. Mining the wealth of data across studies, searching for the patterns within, and discovering knowledge requires tools that augment the user's own expertise. To meet that need, the Next Generation Biobanking software platform provides Qiagram®, the award-winning visual ad hoc query tool. Qiagram puts powerful query and knowledge discovery tools in the hands of the individual researcher. Users "draw" their questions, interactively creating sophisticated queries, without the need to program or struggle with complicated query builders. Answers are presented in configurable visualizations and dashboard widgets that can be shared to generate cross-study, cross-site and cross-group knowledge.

"Based on experiences with many pharmaceutical companies and academic centers, we believe that our Next Generation Biobanking software bridges the gap between conventional biobanking software and the needs of biomarker-based clinical research," commented BioFortis CEO, Jian Wang, PhD, "We consider it critical to empower researchers to perform these kinds of studies and deliver safer and effective clinical outcomes."

The BioFortis Next Generation Biobanking software platform will be demonstrated at Booth #226 at the 2012 Clinical Business Expo, September 19-20, Boston, MA.

About BioFortis, Inc.

BioFortis, Inc. provides enterprise software solutions within several key application areas including translational research, biobanking, biomarker discovery and clinical research. With the ability to centralize life sciences data sets in a tightly-linked, highly-annotated, and user-friendly manner, our products and solutions help customers to standardize on best practices in research data management within the biopharmaceutical industry, academia and government research institutions. For more information visit www.biofortis.com


'/>"/>
SOURCE BioFortis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDSs Marketplace 2012 Trade Convention
2. EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
3. Moving toward regeneration
4. Astrocytes control the generation of new neurons from neural stem cells
5. Natural regeneration building urban forests, altering species composition
6. RIT leads development of next-generation infrared detectors
7. Technology deal for next generation production of green whistle
8. Synthetic diamond steps closer to next generation of high performance electrochemical applications
9. Next-generation sequencing technology opens doors to discoveries
10. Self-assembling nanocubes for next generation antennas and lenses
11. Scientists identify first gene in programmed axon degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, ... web technology, today announced that it has been named to The Silicon Review’s “20 ... services and other markets, Cambridge Semantics serves the needs of end users facing some ...
(Date:4/27/2016)... SPRING, Md. and RESEARCH TRIANGLE ... Therapeutics Corporation (NASDAQ: UTHR ) announced today ... Executive Officer, of United Therapeutics will provide an overview ... Bank 41 st Annual Health Care Conference. ... 5, 2016, at 10:00 a.m. Eastern Time, and can ...
(Date:4/27/2016)... ... 27, 2016 , ... Global Stem Cells Group CEO Benito Novas ... founder of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his ... transplantation for hematologic disorders and the suppression of graft vs. host disease (GVHD) under ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, ... bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of ...
Breaking Biology Technology: